Akzo Nobel Zukünftiges Wachstum
Future Kriterienprüfungen 2/6
Akzo Nobel wird ein jährliches Gewinn- und Umsatzwachstum von 12% bzw. 3% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 12.2% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 20% betragen.
Wichtige Informationen
12.0%
Wachstumsrate der Gewinne
12.2%
EPS-Wachstumsrate
Chemicals Gewinnwachstum | 21.9% |
Wachstumsrate der Einnahmen | 3.0% |
Zukünftige Eigenkapitalrendite | 20.0% |
Analystenabdeckung | Good |
Zuletzt aktualisiert | 08 Nov 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Is Akzo Nobel (AMS:AKZA) A Risky Investment?
Oct 14Why We're Not Concerned About Akzo Nobel N.V.'s (AMS:AKZA) Share Price
Oct 01Akzo Nobel's (AMS:AKZA) Returns On Capital Are Heading Higher
Sep 17What Is Akzo Nobel N.V.'s (AMS:AKZA) Share Price Doing?
Aug 21Akzo Nobel N.V. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Jul 26We Think Akzo Nobel (AMS:AKZA) Can Stay On Top Of Its Debt
Jul 03Akzo Nobel N.V. (AMS:AKZA) Shares Could Be 28% Below Their Intrinsic Value Estimate
Jun 20Akzo Nobel (AMS:AKZA) Is Doing The Right Things To Multiply Its Share Price
Jun 06Market Cool On Akzo Nobel N.V.'s (AMS:AKZA) Earnings
May 10Should You Investigate Akzo Nobel N.V. (AMS:AKZA) At €66.58?
Mar 25We Think Akzo Nobel (AMS:AKZA) Can Stay On Top Of Its Debt
Mar 10Akzo Nobel (AMS:AKZA) Is Doing The Right Things To Multiply Its Share Price
Feb 23Is There An Opportunity With Akzo Nobel N.V.'s (AMS:AKZA) 44% Undervaluation?
Jan 24When Should You Buy Akzo Nobel N.V. (AMS:AKZA)?
Dec 13These 4 Measures Indicate That Akzo Nobel (AMS:AKZA) Is Using Debt Reasonably Well
Nov 02Akzo Nobel N.V.'s (AMS:AKZA) Intrinsic Value Is Potentially 94% Above Its Share Price
Oct 04Why Akzo Nobel N.V. (AMS:AKZA) Could Be Worth Watching
Sep 04Akzo Nobel's (AMS:AKZA) Returns On Capital Are Heading Higher
Aug 07Is Akzo Nobel (AMS:AKZA) A Risky Investment?
Jul 24Akzo Nobel N.V. (AMS:AKZA) Shares Could Be 36% Below Their Intrinsic Value Estimate
Jun 28Is Akzo Nobel N.V. (AMS:AKZA) Potentially Undervalued?
May 31Returns On Capital At Akzo Nobel (AMS:AKZA) Have Hit The Brakes
Apr 28We Think Akzo Nobel (AMS:AKZA) Is Taking Some Risk With Its Debt
Feb 26At €68.92, Is It Time To Put Akzo Nobel N.V. (AMS:AKZA) On Your Watch List?
Feb 12Is Akzo Nobel N.V. (AMS:AKZA) Trading At A 26% Discount?
Jan 16These 4 Measures Indicate That Akzo Nobel (AMS:AKZA) Is Using Debt Extensively
Nov 22Is It Time To Consider Buying Akzo Nobel N.V. (AMS:AKZA)?
Nov 06Akzo Nobel N.V.'s (AMS:AKZA) Intrinsic Value Is Potentially 91% Above Its Share Price
Oct 12Is Akzo Nobel (AMS:AKZA) Using Too Much Debt?
Aug 12Why Akzo Nobel's (AMS:AKZA) Shaky Earnings Are Just The Beginning Of Its Problems
Jul 28Is There Now An Opportunity In Akzo Nobel N.V. (AMS:AKZA)?
Jul 10Akzo Nobel (AMS:AKZA) Has A Pretty Healthy Balance Sheet
May 11Akzo Nobel (AMS:AKZA) Will Pay A Larger Dividend Than Last Year At €1.54
Apr 15At €78.10, Is Akzo Nobel N.V. (AMS:AKZA) Worth Looking At Closely?
Apr 10Akzo Nobel (AMS:AKZA) Is Increasing Its Dividend To €1.54
Mar 27Is There An Opportunity With Akzo Nobel N.V.'s (AMS:AKZA) 47% Undervaluation?
Mar 22Akzo Nobel's (AMS:AKZA) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 06Akzo Nobel (AMS:AKZA) Is Paying Out A Larger Dividend Than Last Year
Feb 20Here's Why We Think Akzo Nobel (AMS:AKZA) Is Well Worth Watching
Jan 13Is Akzo Nobel (AMS:AKZA) A Risky Investment?
Jan 02Are Investors Undervaluing Akzo Nobel N.V. (AMS:AKZA) By 38%?
Dec 20Is There Now An Opportunity In Akzo Nobel N.V. (AMS:AKZA)?
Dec 08Gewinn- und Umsatzwachstumsprognosen
Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
---|---|---|---|---|---|
12/31/2026 | 11,281 | 784 | 791 | 1,154 | 16 |
12/31/2025 | 10,960 | 670 | 697 | 1,061 | 17 |
12/31/2024 | 10,676 | 596 | 597 | 936 | 14 |
9/30/2024 | 10,621 | 565 | 536 | 842 | N/A |
6/30/2024 | 10,694 | 592 | 561 | 844 | N/A |
3/31/2024 | 10,651 | 534 | 733 | 998 | N/A |
12/31/2023 | 10,668 | 447 | 834 | 1,120 | N/A |
9/30/2023 | 10,745 | 411 | 572 | 840 | N/A |
6/30/2023 | 10,866 | 309 | 375 | 661 | N/A |
3/31/2023 | 10,978 | 303 | 8 | 305 | N/A |
12/31/2022 | 10,846 | 362 | -38 | 254 | N/A |
9/30/2022 | 10,643 | 540 | -155 | 140 | N/A |
6/30/2022 | 10,191 | 616 | 20 | 313 | N/A |
3/31/2022 | 9,849 | 758 | 245 | 533 | N/A |
12/31/2021 | 9,587 | 823 | 316 | 604 | N/A |
9/30/2021 | 9,393 | 805 | 750 | 1,041 | N/A |
6/30/2021 | 9,259 | 866 | 922 | 1,207 | N/A |
3/31/2021 | 8,735 | 741 | 1,078 | 1,347 | N/A |
12/31/2020 | 8,530 | 637 | 959 | 1,217 | N/A |
9/30/2020 | 8,563 | 544 | 817 | 1,052 | N/A |
6/30/2020 | 8,685 | 481 | 681 | 904 | N/A |
3/31/2020 | 9,149 | 567 | 524 | 747 | N/A |
12/31/2019 | 9,276 | 517 | -191 | 23 | N/A |
9/30/2019 | 9,342 | 477 | 11 | 210 | N/A |
6/30/2019 | 9,270 | 463 | 32 | 220 | N/A |
3/31/2019 | 9,265 | 354 | -100 | 84 | N/A |
12/31/2018 | 9,256 | 400 | 329 | 513 | N/A |
9/30/2018 | 9,231 | 393 | 447 | 652 | N/A |
6/30/2018 | 9,324 | 365 | N/A | 671 | N/A |
3/31/2018 | 9,411 | 426 | N/A | 882 | N/A |
12/31/2017 | 9,612 | 439 | N/A | 969 | N/A |
9/30/2017 | 6,022 | 107 | N/A | 772 | N/A |
6/30/2017 | 7,203 | 272 | N/A | 1,035 | N/A |
3/31/2017 | 8,381 | 417 | N/A | 1,261 | N/A |
12/31/2016 | 9,434 | 534 | N/A | 1,291 | N/A |
9/30/2016 | 14,300 | 1,032 | N/A | 1,477 | N/A |
6/30/2016 | 14,460 | 1,031 | N/A | 1,460 | N/A |
3/31/2016 | 14,698 | 1,051 | N/A | 1,414 | N/A |
12/31/2015 | 14,859 | 973 | N/A | 1,130 | N/A |
9/30/2015 | 14,817 | 772 | N/A | 784 | N/A |
6/30/2015 | 14,743 | 691 | N/A | 679 | N/A |
3/31/2015 | 14,504 | 565 | N/A | 655 | N/A |
12/31/2014 | 14,296 | 528 | N/A | 723 | N/A |
9/30/2014 | 14,261 | 570 | N/A | 597 | N/A |
6/30/2014 | 14,353 | 521 | N/A | 671 | N/A |
3/31/2014 | 14,508 | 623 | N/A | 1,329 | N/A |
12/31/2013 | 14,590 | 593 | N/A | 1,391 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: AKZADas prognostizierte Gewinnwachstum (12% pro Jahr) liegt über der Sparquote (1.2%).
Ertrag vs. Markt: AKZADie Erträge des Unternehmens (12% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Dutch (16.2% pro Jahr).
Hohe Wachstumserträge: AKZADie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: AKZADie Einnahmen des Unternehmens (3% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Dutch (8.6% pro Jahr).
Hohe Wachstumseinnahmen: AKZADie Einnahmen des Unternehmens (3% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: AKZADie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich hoch sein (20%)